DBV Technologies (DBVT) Competitors $8.77 -0.56 (-6.00%) Closing price 04:00 PM EasternExtended Trading$8.76 -0.01 (-0.11%) As of 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DBVT vs. BGM, AUPH, WVE, GYRE, PAHC, MLYS, COLL, SNDX, RCUS, and ELVNShould you be buying DBV Technologies stock or one of its competitors? The main competitors of DBV Technologies include Qilian International Holding Group (BGM), Aurinia Pharmaceuticals (AUPH), Wave Life Sciences (WVE), Gyre Therapeutics (GYRE), Phibro Animal Health (PAHC), Mineralys Therapeutics (MLYS), Collegium Pharmaceutical (COLL), Syndax Pharmaceuticals (SNDX), Arcus Biosciences (RCUS), and Enliven Therapeutics (ELVN). These companies are all part of the "pharmaceutical products" industry. DBV Technologies vs. Qilian International Holding Group Aurinia Pharmaceuticals Wave Life Sciences Gyre Therapeutics Phibro Animal Health Mineralys Therapeutics Collegium Pharmaceutical Syndax Pharmaceuticals Arcus Biosciences Enliven Therapeutics Qilian International Holding Group (NASDAQ:BGM) and DBV Technologies (NASDAQ:DBVT) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment. Which has more volatility and risk, BGM or DBVT? Qilian International Holding Group has a beta of 1.33, suggesting that its share price is 33% more volatile than the S&P 500. Comparatively, DBV Technologies has a beta of -0.66, suggesting that its share price is 166% less volatile than the S&P 500. Which has preferable earnings & valuation, BGM or DBVT? Qilian International Holding Group has higher revenue and earnings than DBV Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQilian International Holding Group$25.10M49.74-$1.44MN/AN/ADBV Technologies$15.73M15.27-$72.73M-$4.92-1.78 Does the MarketBeat Community prefer BGM or DBVT? DBV Technologies received 407 more outperform votes than Qilian International Holding Group when rated by MarketBeat users. CompanyUnderperformOutperformQilian International Holding GroupN/AN/ADBV TechnologiesOutperform Votes40754.12% Underperform Votes34545.88% Does the media prefer BGM or DBVT? In the previous week, DBV Technologies had 1 more articles in the media than Qilian International Holding Group. MarketBeat recorded 1 mentions for DBV Technologies and 0 mentions for Qilian International Holding Group. DBV Technologies' average media sentiment score of 0.49 beat Qilian International Holding Group's score of 0.00 indicating that DBV Technologies is being referred to more favorably in the news media. Company Overall Sentiment Qilian International Holding Group Neutral DBV Technologies Neutral Is BGM or DBVT more profitable? Qilian International Holding Group has a net margin of 0.00% compared to DBV Technologies' net margin of -815.73%. Qilian International Holding Group's return on equity of 0.00% beat DBV Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Qilian International Holding GroupN/A N/A N/A DBV Technologies -815.73%-106.07%-76.17% Do analysts rate BGM or DBVT? DBV Technologies has a consensus target price of $15.50, indicating a potential upside of 76.74%. Given DBV Technologies' stronger consensus rating and higher probable upside, analysts clearly believe DBV Technologies is more favorable than Qilian International Holding Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qilian International Holding Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00DBV Technologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in BGM or DBVT? 71.7% of DBV Technologies shares are owned by institutional investors. 58.7% of Qilian International Holding Group shares are owned by company insiders. Comparatively, 1.9% of DBV Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryQilian International Holding Group beats DBV Technologies on 8 of the 15 factors compared between the two stocks. Get DBV Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DBVT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DBVT vs. The Competition Export to ExcelMetricDBV TechnologiesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$240.21M$2.93B$5.33B$8.39BDividend YieldN/A1.68%5.21%4.11%P/E Ratio-1.9531.1826.7119.71Price / Sales15.27398.76386.12120.59Price / CashN/A168.6838.2534.62Price / Book1.213.236.774.50Net Income-$72.73M-$72.35M$3.23B$248.22M7 Day Performance-22.11%5.01%1.80%0.56%1 Month Performance0.23%5.63%11.10%13.17%1 Year Performance41.93%-27.04%17.11%7.30% DBV Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DBVTDBV Technologies2.7865 of 5 stars$8.77-6.0%$15.50+76.7%+48.6%$240.21M$15.73M-1.9580Gap DownBGMQilian International Holding GroupN/A$11.42+3.5%N/AN/A$1.11B$25.10M0.00298Positive NewsGap UpAUPHAurinia Pharmaceuticals2.4267 of 5 stars$8.12+1.5%$11.50+41.6%+49.2%$1.11B$235.13M-54.13300WVEWave Life Sciences4.3806 of 5 stars$6.60+0.2%$21.17+220.7%-4.4%$1.02B$108.30M-5.95240Positive NewsGYREGyre Therapeutics0.2894 of 5 stars$10.83+13.6%N/A-20.8%$1.02B$105.76M541.5040News CoveragePAHCPhibro Animal Health3.5275 of 5 stars$24.50+9.0%$20.00-18.4%+26.6%$992.32M$1.11B51.041,860Positive NewsMLYSMineralys Therapeutics2.8848 of 5 stars$15.01+2.5%$33.00+119.9%+29.0%$973.79MN/A-4.1228Analyst UpgradeCOLLCollegium Pharmaceutical4.0592 of 5 stars$29.56+2.3%$43.80+48.2%-14.6%$949.82M$631.45M12.74210Positive NewsSNDXSyndax Pharmaceuticals3.8277 of 5 stars$10.99+2.7%$35.91+226.7%-48.5%$945.66M$43.72M-3.03110Positive NewsRCUSArcus Biosciences3.6663 of 5 stars$8.82+6.5%$25.67+191.2%-49.9%$933.38M$141M-2.80500Positive NewsHigh Trading VolumeELVNEnliven Therapeutics2.4849 of 5 stars$19.01+3.2%$40.33+112.2%-26.1%$932.75MN/A-10.0150News CoverageAnalyst Revision Related Companies and Tools Related Companies Qilian International Holding Group Alternatives Aurinia Pharmaceuticals Alternatives Wave Life Sciences Alternatives Gyre Therapeutics Alternatives Phibro Animal Health Alternatives Mineralys Therapeutics Alternatives Collegium Pharmaceutical Alternatives Syndax Pharmaceuticals Alternatives Arcus Biosciences Alternatives Enliven Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DBVT) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DBV Technologies S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share DBV Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DBVT Stock Free DBVT Stock Alerts